PDT Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,031
| Closed | -$220K | – | 990 |
|
|
2022
Q1 | $220K | Buy |
+10,031
| New | +$220K | 0.02% | 797 |
|
|
2021
Q3 | – | Sell |
-11,410
| Closed | -$215K | – | 792 |
|
|
2021
Q2 | $215K | Sell |
11,410
-3,129
| -22% | -$59K | 0.01% | 688 |
|
|
2021
Q1 | $222K | Sell |
14,539
-12,260
| -46% | -$187K | 0.02% | 682 |
|
|
2020
Q4 | $378K | Buy |
26,799
+3,558
| +15% | +$50.2K | 0.03% | 503 |
|
|
2020
Q3 | $364K | Buy |
+23,241
| New | +$364K | 0.02% | 516 |
|